ePrints

A Risk-Benefit Analysis of Natalizumab Across PML Risk Sub-Groups in Patients with Relapsing-Remitting Multiple Sclerosis

Lookup NU author(s): Emeritus Professor David Bates

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Publication metadata

Author(s): Walker AR, Deniz B, Alexopoulos ST, Arnold R, Bates D

Publication type: Conference Proceedings (inc. Abstract)

Publication status: Published

Conference Name: ISPOR 17th Annual International Meeting

Year of Conference: 2012

Pages: A140-A141

ISSN: 1524-4733

Publisher: Elsevier

URL: http://dx.doi.org/10.1016/j.jval.2012.03.760

DOI: 10.1016/j.jval.2012.03.760

Series Title: Value in Health

Share